Listener discretion is advised
Retatrutide, like other incretin-based therapies, slows gastric motility
Results demonstrated that tirzepatide achieved MASH resolution without worsening fibrosis in approximately 44% (5 mg), 56% (10 mg), and 62% (15 mg) of participants , compared to about 10% in the placebo group
Common side effects include: Injection Site Reactions: Soreness, redness, or swelling at the injection site can occur
Medicinal plants for allergic rhinitis: a systematic review and meta-analysis
Supplementation with aged garlic extract improves both NK and -T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention